Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01516788 · ClinicalTrials.gov registry record · NA

Photoprovocation Testing in Subjects With Cutaneous Lupus

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT01516788: Completed NA study, sponsored by University of Pennsylvania.

NCT01516788 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01516788, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

Photosensitivity is well documented among lupus patients and is one of the diagnostic criteria for systemic lupus erythematosus (SLE). Photosensitivity is highly prevalent in lupus and has a wide range of clinical presentations. However, photosensitivity is a poorly defined in lupus and its pathogenesis is not well understood. The purpose of this study is to characterize the early clinical and histopathological changes in lupus skin that occur as a response to ultraviolet light.

Interventions

  • OTHER Phototesting

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2011-12
Est. Completion 2018-07-02
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01516788

The ClinicalTrials.gov registry entry for NCT01516788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Phototesting is the first listed.

NCT01516788 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01516788 about?

NCT01516788 is a clinical study titled "Photoprovocation Testing in Subjects With Cutaneous Lupus". Photosensitivity is well documented among lupus patients and is one of the diagnostic criteria for systemic lupus erythematosus (SLE). Photosensitivity is highly prevalent in lupus and has a wide range of clinical presentations. However, photosensitivity is a poorly defined in lupus and its pathogen...

What is the current status of trial NCT01516788?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2011-12. Estimated completion is 2018-07-02.

What interventions are being tested in trial NCT01516788?

The interventions under investigation include: Phototesting (OTHER).

Who is sponsoring clinical trial NCT01516788?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.